Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...
Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved FerabrightTM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback